Also known as: Saliva secretion increased / Saliva increased / Hypoptyalism / Sialosis / Increased salivation / Sialorrhoea / Hypersalivation / Saliva secretion excessive / Salivary hypersecretion / Ptyalism

DrugDrug NameDrug Description
DB00042Botulinum Toxin Type BNeurotoxin produced by fermentation of clostridium botulinum type B. The protein exists in noncovalent association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin complex. The neurotoxin complex is recovered from the fermentation process and purified through a series of precipitation and chromatography steps.
DB00083Botulinum toxin type APurified botulinum toxin from Clostridium botulinum, purified from culture via dialysis and acid precipitation.
DrugDrug NamePhaseStatusCount
DB00986Glycopyrronium1 / 2Completed1
DB00747Scopolamine1 / 2Completed1
DB00083Botulinum toxin type A2Completed2
DB00332Ipratropium2Not Yet Recruiting1
DB00042Botulinum Toxin Type B2 / 3Completed1
DB00083Botulinum toxin type A2 / 3Completed1
DB00083Botulinum toxin type A2 / 3Unknown Status1
DB00042Botulinum Toxin Type B3Completed2
DB00572AtropineNot AvailableCompleted1
DB00363ClozapineNot AvailableCompleted1
DB00986GlycopyrroniumNot AvailableCompleted1
DB00424HyoscyamineNot AvailableCompleted1
DB01221KetamineNot AvailableCompleted1
DB09153Sodium chlorideNot AvailableCompleted1